Trials / Conditions / AATD
AATD
6 registered clinical trials studyying AATD — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110 NCT06677307 | Korro Bio, Inc. | Phase 1 / Phase 2 |
| Withdrawn | NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease NCT06622668 | Intellia Therapeutics | Phase 1 / Phase 2 |
| Completed | Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency NCT03815396 | Inhibrx Biosciences, Inc | Phase 1 |
| Completed | Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) NCT01810458 | University of Florida | — |
| Completed | Genomic Research in Alpha-1 Antitrypsin Deficiency NCT01832220 | University of Pittsburgh | — |
| Recruiting | Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs NCT01851642 | University of Florida | — |